Epstein-Barr virus (EBV) is the primary cause of infectious mononucleosis, commonly called mono. About 90% of mono cases are caused by EBV, with the remaining 10% caused by other viruses, most commonly cytomegalovirus. The two terms are closely linked but not identical: EBV is the virus, and mono is the illness it can trigger. Here’s the key distinction: nearly everyone gets infected with EBV at some point, but only a fraction of those people ever develop mono.
Why EBV Doesn’t Always Cause Mono
About 9 out of 10 adults carry antibodies showing they’ve been infected with EBV at some point in their lives. Most of those people were infected during childhood and never had any symptoms at all. When young children catch EBV, the infection typically passes silently, looking like any other mild cold or producing no noticeable illness whatsoever.
Mono tends to show up when EBV infection is delayed until adolescence or early adulthood. At that age, the immune system mounts a much more aggressive response to the virus, and that intense immune reaction is what produces the classic symptoms: extreme fatigue, sore throat, swollen lymph nodes, and fever. So the symptoms of mono aren’t caused directly by the virus destroying tissue. They’re caused by your own immune system fighting back hard.
How EBV Spreads and Takes Hold
EBV spreads primarily through saliva, which is why mono earned the nickname “the kissing disease.” Sharing drinks, utensils, or toothbrushes can also transmit it. Once the virus enters your body, it targets a specific type of white blood cell called a B cell. The virus latches onto a receptor on the surface of these cells, gets pulled inside, and begins replicating. After the initial infection is controlled, EBV doesn’t leave your body. It goes dormant inside B cells and stays there for life, occasionally reactivating at low levels without causing symptoms.
Symptoms and Timeline
Symptoms typically appear 4 to 6 weeks after infection, a notably long incubation period compared to most common viruses. The hallmark symptoms are severe fatigue, a very sore throat (often with white patches on the tonsils), swollen glands in the neck and armpits, and fever. Some people also develop an enlarged spleen or liver, and a small percentage get a body-wide rash.
Most people start feeling better within 2 to 4 weeks, though fatigue can linger for several more weeks after the other symptoms resolve. In some cases, symptoms persist for 6 months or longer. There’s no antiviral medication that shortens mono. Treatment focuses on rest, fluids, and over-the-counter pain relief for fever and throat pain.
The Spleen Risk and Exercise
One of the more serious concerns during mono is an enlarged spleen, which becomes vulnerable to rupture from physical impact. This is why doctors commonly advise avoiding vigorous physical activity and contact sports for at least 4 to 6 weeks after symptoms begin. Light activities like jogging or swimming may be safe to resume after about 3 weeks, but strenuous contact sports carry risk for up to 8 weeks. If you’re eager to return to high-impact activities sooner, an ultrasound can confirm whether your spleen has returned to normal size.
Other Viruses That Mimic Mono
Since about 10% of mono cases aren’t caused by EBV, it’s worth knowing what else can produce a similar illness. Cytomegalovirus is the most common alternative cause and produces nearly identical symptoms. Other possibilities include human herpesvirus 6, adenovirus, and herpes simplex. Acute HIV infection can also look like mono early on, though it tends to include additional symptoms like rash, weight loss, and diarrhea. Toxoplasmosis, a parasitic infection linked to undercooked meat or cat litter exposure, can also cause mono-like symptoms and may even trigger a false positive on the standard mono screening test.
How EBV Infection Is Confirmed
A quick “monospot” test detects general antibodies and can confirm mono in many cases, but specific EBV blood tests give a more precise picture. These tests look for different types of antibodies that appear and disappear on a predictable schedule.
During an active infection, your blood will show one type of antibody (anti-VCA IgM) that appears early and fades within 4 to 6 weeks. Another antibody (anti-VCA IgG) also rises during the acute phase but stays in your blood permanently. A third antibody (EBNA) doesn’t appear until 2 to 4 months after symptoms begin and also persists for life. If a blood test shows the early antibody but not the delayed one, that points to a new infection. If both are present, the infection happened months or years ago.
Long-Term Health Associations
For most people, EBV infection is a one-time event with no lasting consequences. But research has uncovered a striking connection between EBV and multiple sclerosis. More than 99% of people with MS have been infected with EBV, compared to 90 to 95% of the general population. A landmark study found that EBV infection increases the risk of developing MS by 32-fold, with a median gap of about 5 years between infection and diagnosis. People who experienced symptomatic mono (rather than a silent childhood infection) have more than double the MS risk compared to those who were infected without symptoms.
This doesn’t mean mono leads to MS in any but a tiny fraction of cases. MS remains relatively rare. But the association is strong enough that researchers are actively pursuing an EBV vaccine partly in hopes of reducing MS rates. A clinical trial of an mRNA-based EBV vaccine enrolled 867 adolescents and young adults beginning in late 2021, with results expected in 2026.